Prospective multicenter disease registry using SCRUM-Japan as an external control group for marketing authorization for pharmaceuticals

Not Applicable

Recruiting

• Conditions: nresectable solid malignancies

• Registration Number: JPRN-UMIN000028058
• Lead Sponsor: ational Research and Development Agency, National Cancer Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-03
• Last Update Posted: 17 October 2023
• Study Completion: 2026-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 630

Inclusion Criteria

Not provided

Exclusion Criteria

Subjects have any reason, in the opinion of the investigator, that would preclude participation in this research.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response Rate

Secondary Outcome Measures

Name	Time	Method
Progression Free Survival, Duration of Response, Time to Treatment Failure, Disease Control Rate, and Overall Survival